blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1641455

EP1641455 - PYRAZOLO[3,4-B]PYRIDIN-6-ONES AS GSK-3 INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.06.2009
Database last updated on 11.11.2024
Most recent event   Tooltip30.09.2011Lapse of the patent in a contracting state
New state(s): CY, TR
published on 02.11.2011  [2011/44]
Applicant(s)For all designated states
Pfizer Products Inc.
Eastern Point Road
Groton, CT 06340 / US
[2008/32]
Former [2006/14]For all designated states
Pfizer Products Inc.
Eastern Point Road Groton
Connecticut 06340 / US
Inventor(s)01 / KUNG, Daniel Wei-Shung, Pfizer Global R & D
Eastern Point Road
Groton, CT 06340 / US
02 / WAGER, Travis T., Pfizer Global R & D
Eastern Point Road
Groton, CT 06340 / US
 [2006/14]
Representative(s)Dekker, Henrike Cornelie Christine, et al
Pfizer Limited
European Patent Department
Ramsgate Road
Sandwich
Kent CT13 9NJ / GB
[N/P]
Former [2009/20]Dekker, Henrike Cornelie Christine, et al
Pfizer Limited European Patent Department Ramsgate Road Sandwich
Kent CT13 9NJ / GB
Former [2006/33]Dekker, Henrike Cornelie Christine, et al
Pfizer European Pharma Patent Department 23-25, avenue du Docteur Lannelongue
75668 Paris Cedex 14 / FR
Former [2006/14]Peter, Beate
Pfizer Limited Ramsgate Road
GB-Sandwich, Kent CT13 9NJ / GB
Application number, filing date04736783.414.06.2004
[2006/14]
WO2004IB02026
Priority number, dateUS20030483201P27.06.2003         Original published format: US 483201 P
[2006/14]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005000304
Date:06.01.2005
Language:EN
[2005/01]
Type: A1 Application with search report 
No.:EP1641455
Date:05.04.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 06.01.2005 takes the place of the publication of the European patent application.
[2006/14]
Type: B1 Patent specification 
No.:EP1641455
Date:06.08.2008
Language:EN
[2008/32]
Search report(s)International search report - published on:EP06.01.2005
ClassificationIPC:A61K31/437, C07D471/04, A61P25/24, A61P25/28, A61P35/00
[2006/14]
CPC:
C07D471/04 (EP,US); A61K31/437 (EP,US); A61K31/4745 (EP,US);
A61K45/06 (EP,US); A61P11/06 (EP); A61P15/00 (EP);
A61P17/14 (EP); A61P25/00 (EP); A61P25/18 (EP);
A61P25/22 (EP); A61P25/24 (EP); A61P25/28 (EP);
A61P29/00 (EP); A61P3/04 (EP); A61P3/06 (EP);
A61P3/10 (EP); A61P35/00 (EP); A61P43/00 (EP);
A61P9/00 (EP); A61P9/04 (EP); A61P9/10 (EP);
A61P9/12 (EP) (-)
C-Set:
A61K31/437, A61K2300/00 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/14]
Extension statesALNot yet paid
HRNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:PYRAZOLO[3,4-B]PYRIDIN-6-ONE ALS GSK-3 INHIBITOREN[2006/14]
English:PYRAZOLO[3,4-B]PYRIDIN-6-ONES AS GSK-3 INHIBITORS[2006/14]
French:PYRAZOLO[3,4-B]PYRIDIN-6-ONES EN TANT QU'INHIBITEURS DE LA GSK-3[2006/14]
Entry into regional phase27.01.2006National basic fee paid 
27.01.2006Designation fee(s) paid 
27.01.2006Examination fee paid 
Examination procedure11.11.2004Request for preliminary examination filed
International Preliminary Examining Authority: EP
13.01.2006Amendment by applicant (claims and/or description)
27.01.2006Examination requested  [2006/14]
21.02.2007Despatch of a communication from the examining division (Time limit: M04)
19.06.2007Reply to a communication from the examining division
18.07.2007Despatch of a communication from the examining division (Time limit: M04)
21.11.2007Reply to a communication from the examining division
25.02.2008Communication of intention to grant the patent
19.06.2008Fee for grant paid
19.06.2008Fee for publishing/printing paid
Opposition(s)07.05.2009No opposition filed within time limit [2009/29]
Fees paidRenewal fee
30.06.2006Renewal fee patent year 03
02.07.2007Renewal fee patent year 04
30.06.2008Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT06.08.2008
BE06.08.2008
CY06.08.2008
CZ06.08.2008
DK06.08.2008
EE06.08.2008
FI06.08.2008
NL06.08.2008
PL06.08.2008
RO06.08.2008
SI06.08.2008
SK06.08.2008
TR06.08.2008
BG06.11.2008
SE06.11.2008
GR07.11.2008
PT06.01.2009
HU07.02.2009
[2011/43]
Former [2011/32]AT06.08.2008
BE06.08.2008
CZ06.08.2008
DK06.08.2008
EE06.08.2008
FI06.08.2008
NL06.08.2008
PL06.08.2008
RO06.08.2008
SI06.08.2008
SK06.08.2008
BG06.11.2008
SE06.11.2008
GR07.11.2008
PT06.01.2009
HU07.02.2009
Former [2010/50]AT06.08.2008
BE06.08.2008
CZ06.08.2008
DK06.08.2008
EE06.08.2008
FI06.08.2008
NL06.08.2008
PL06.08.2008
RO06.08.2008
SI06.08.2008
SK06.08.2008
BG06.11.2008
SE06.11.2008
GR07.11.2008
PT06.01.2009
Former [2010/24]AT06.08.2008
BE06.08.2008
CZ06.08.2008
DK06.08.2008
EE06.08.2008
FI06.08.2008
NL06.08.2008
PL06.08.2008
RO06.08.2008
SI06.08.2008
SK06.08.2008
BG06.11.2008
SE06.11.2008
PT06.01.2009
Former [2010/10]AT06.08.2008
BE06.08.2008
CZ06.08.2008
DK06.08.2008
EE06.08.2008
FI06.08.2008
NL06.08.2008
RO06.08.2008
SI06.08.2008
SK06.08.2008
BG06.11.2008
SE06.11.2008
PT06.01.2009
Former [2009/36]AT06.08.2008
BE06.08.2008
CZ06.08.2008
DK06.08.2008
EE06.08.2008
FI06.08.2008
NL06.08.2008
RO06.08.2008
SI06.08.2008
SK06.08.2008
BG06.11.2008
PT06.01.2009
Former [2009/26]AT06.08.2008
BE06.08.2008
CZ06.08.2008
DK06.08.2008
FI06.08.2008
NL06.08.2008
RO06.08.2008
SI06.08.2008
SK06.08.2008
BG06.11.2008
PT06.01.2009
Former [2009/24]AT06.08.2008
BE06.08.2008
CZ06.08.2008
DK06.08.2008
FI06.08.2008
NL06.08.2008
SI06.08.2008
SK06.08.2008
BG06.11.2008
Former [2009/23]AT06.08.2008
BE06.08.2008
DK06.08.2008
FI06.08.2008
NL06.08.2008
SI06.08.2008
BG06.11.2008
Former [2009/19]AT06.08.2008
BE06.08.2008
DK06.08.2008
FI06.08.2008
NL06.08.2008
SI06.08.2008
Former [2009/15]AT06.08.2008
FI06.08.2008
NL06.08.2008
SI06.08.2008
Former [2009/12]FI06.08.2008
NL06.08.2008
Cited inInternational search[A]US4020072  (HOEHN HANS) [A] 1-4* Formula I and Va (col. 3);; example 5a *;
 [A]WO0224694  (SMITHKLINE BEECHAM PLC [GB], et al) [A] 1-12 * the whole document *;
 [A]WO03045949  (SMITHKLINE BEECHAM PLC [GB], et al) [A] 1-12 * the whole document *;
 [A]  - QUIROGA, JAIRO ET AL, "Synthesis, molecular structure and tautomerism of 1(2)H-dihydropyrazolo[3,4-b]pyridin-6-ones Synthesis, molecular structure and tautomerism of 1(2)H-dihydropyrazolo[3,4-b]pyridin-6-ones", HETEROCYCLIC COMMUNICATIONS , 5(2), 115-122 CODEN: HCOMEX; ISSN: 0793-0283, (1999), XP009035728 [A] 1 * compounds 4,5A-F *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.